Cargando…
Successful use of endobronchial valve for persistent air leak in a patient with COVID-19 and bullous emphysema
Patients with SARS-CoV-2 pneumonia can suffer from pneumothorax and persistent air leak (PAL). The pneumothorax occurs with or without pre-existing lung disease. PAL refers to air leak lasting more than 5–7 days and arises due to bronchopleural or alveolopleural fistula. The management of PAL can be...
Autores principales: | Saha, Biplab K, Bonnier, Alyssa, Chong, Woon Hean, Chenna, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606771/ https://www.ncbi.nlm.nih.gov/pubmed/34799393 http://dx.doi.org/10.1136/bcr-2021-246671 |
Ejemplares similares
-
Persistent air leak successfully treated with endobronchial valves and digital drainage system
por: Altree, Thomas James, et al.
Publicado: (2018) -
New pneumothorax complicating successful treatment of persistent air leak by endobronchial valves
por: Yeung, Yiu Cheong, et al.
Publicado: (2021) -
Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019
por: Ahmed, Hanad, et al.
Publicado: (2022) -
Case report: Endobronchial valve placement for treatment of a persistent air leak
por: Morrison, Morvern, et al.
Publicado: (2016) -
Endobronchial one‐way valve for persistent air leak and lung volume reduction
por: Yu, Wai Cho, et al.
Publicado: (2019)